ABCC7 p.Tyr517Ala
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 15673927
[PubMed]
Tsigelny I et al: "Identification of molecular determinants that modulate trafficking of DeltaF508 CFTR, the mutant ABC transporter associated with cystic fibrosis."
No.
Sentence
Comment
172
The putative basic amino acid and tyrosine-based trafficking signals were altered by site-directed mutagenesis to eliminate the canonical trafficking signal sequences at the 516-520 site by changing the Tyr-517 and Arg-518 residues to Ala (this variant designated Y517A:R518A ∆F508 CFTR).
X
ABCC7 p.Tyr517Ala 15673927:172:203
status: NEWX
ABCC7 p.Tyr517Ala 15673927:172:264
status: NEW190 Of the modifications examined, only the double mutation Y517A:R518A in the ∆F508 CFTR template (designated Y517A:R518A ∆F508 CFTR) appeared to enhance the cell surface expression (Fig. 7A).
X
ABCC7 p.Tyr517Ala 15673927:190:56
status: NEWX
ABCC7 p.Tyr517Ala 15673927:190:114
status: NEW191 In cells transfected with Y517A:R518A ∆F508 CFTR, both intracellular and the cell boundary regions revealed immunofluorescent stain (Fig. 7A).
X
ABCC7 p.Tyr517Ala 15673927:191:26
status: NEW192 Fluorescent emission at the cell boundary is consistent with the interpretation that Y517A:R518A ∆F508 CFTR was delivered to the cell surface.
X
ABCC7 p.Tyr517Ala 15673927:192:85
status: NEW197 Because expression of ∆F508 CFTR and single alterations in the ∆F508 CFTR template did not correspond with fluorescent emission at the cell periphery, whereas expression of wild-type CFTR and Y517A:R518A ∆F508 CFTR was reflected in detection of fluorescent emission at the cell boundary, we conclude that elimination of the specific tyrosine-based and basic amino acid signals elevated delivery of ∆F508 CFTR to the plasma membrane.
X
ABCC7 p.Tyr517Ala 15673927:197:206
status: NEW203 Western Blot Analysis We expressed wild-type CFTR, ∆F508 CFTR, and Y517A:R518A ∆F508 CFTR in HEK cells using equivalent amount of plasmids and cells, and processed the cell lysates identically for Western blotting.
X
ABCC7 p.Tyr517Ala 15673927:203:74
status: NEW205 A B-band was associated with ∆F508 CFTR (Fig. 7B, lane 1) and Y517A:R518A ∆F508 CFTR (Fig. 7B, lane 3).
X
ABCC7 p.Tyr517Ala 15673927:205:69
status: NEW207 Although ∆F508 CFTR lacked a C-band (Fig. 7B, lane 1), Y517A:R518A ∆F508 CFTR revealed a C-band (Fig. 7B, lane 3), albeit significantly fainter than the C-band associated with wild-type CFTR (Fig. 7B, lane 2).
X
ABCC7 p.Tyr517Ala 15673927:207:62
status: NEW208 The appearance of the C-band associated with Y517A:R518A ∆F508 CFTR indicated that the sequence alteration elevated the upstream trafficking of ∆F508 CFTR.
X
ABCC7 p.Tyr517Ala 15673927:208:45
status: NEW209 Since the Y517A:R518A alterations did not quantitatively restore trafficking levels comparable to wild-type CFTR (Fig. 7B, compare lanes and 3), addi- 50 Tsigelny et al. Cell Biochemistry and Biophysics Volume 42, 2005 Fig. 6.
X
ABCC7 p.Tyr517Ala 15673927:209:10
status: NEW215 (A) Confocal-immunofluorescent images of ∆F508 CFTR, wild-type, and Y517A:R518A ∆F508 CFTR expressed transiently in human embryonic kidney cells.
X
ABCC7 p.Tyr517Ala 15673927:215:75
status: NEW217 Immunofluorescent stain at the cell surface (CS) is apparent in the cells expressing wild-type and Y517A:R518A ∆F508 CFTR.
X
ABCC7 p.Tyr517Ala 15673927:217:99
status: NEW219 (B) Western blot of lysates from cells expressing ∆F508 CFTR, wild-type, and Y517A:R518A ∆F508 CFTR.
X
ABCC7 p.Tyr517Ala 15673927:219:84
status: NEW225 Lane 3, Y517A:R518A ∆F508 CFTR.
X
ABCC7 p.Tyr517Ala 15673927:225:8
status: NEW
PMID: 16131493
[PubMed]
Swiatecka-Urban A et al: "The short apical membrane half-life of rescued {Delta}F508-cystic fibrosis transmembrane conductance regulator (CFTR) results from accelerated endocytosis of {Delta}F508-CFTR in polarized human airway epithelial cells."
No.
Sentence
Comment
52
To construct the GFP-⌬F508-CFTR Y517A mutant, the GFP-⌬F508-CFTR cDNA sequence in pcDNA3.1 was mutated using the QuikChangeTM XL site-directed mutagenesis kit (Stratagene; La Jolla, CA).
X
ABCC7 p.Tyr517Ala 16131493:52:39
status: NEW54 Transient transfection of the GFP-tagged CFTR cDNAs into parental CFBE41o-cells was performed using LipofectamineTM 2000 according to the manufacturer`s instructions. CFBE41o-cells grown on 40-mm tissue culture plates were incubated for 24 h with the transfection mixture (2 g of cDNA and 4 l of LipofectamineTM 2000 per plate) at 37 °C. Subsequently, cells were cultured in fresh medium at 27 °C for 36 h to increase the expression of GFP-⌬F508-CFTR and GFP-⌬F508-CFTR Y517A in the plasma membrane.
X
ABCC7 p.Tyr517Ala 16131493:54:510
status: NEW64 Parental CFBE41o-cells transiently transfected with either GFP- ⌬F508-CFTR or GFP-⌬F508-CFTR Y517A were grown on plastic tissue culture plates.
X
ABCC7 p.Tyr517Ala 16131493:64:107
status: NEW161 To test this hypothesis, we transiently expressed the GFP-tagged ⌬F508-CFTR or the GFP-⌬F508-CFTR Y517A mutant in parental CFBE41o-cells.
X
ABCC7 p.Tyr517Ala 16131493:161:112
status: NEW164 The apical membrane expression of GFP-⌬F508-CFTR and GFP-⌬F508-CFTR Y517A was similar at steady state (Fig. 7A).
X
ABCC7 p.Tyr517Ala 16131493:164:82
status: NEW165 Furthermore, as illustrated in Figs. 7, B and C, the apical membrane half-life of GFP-⌬F508-CFTR Y517A (1.0 h) did not differ from that of GFP-⌬F508-CFTR (1.1 h).
X
ABCC7 p.Tyr517Ala 16131493:165:104
status: NEW194 FIGURE 7. Summary of experiments performed to determine the effects of the Y517A mutation in ⌬F508-CFTR on the apical membrane expression at steady state and the apical membrane half-life of rescued ⌬F508-CFTR.
X
ABCC7 p.Tyr517Ala 16131493:194:75
status: NEW195 Parental CFBE41o-cells grown on plastic tissue culture plates were transiently transfected with either GFP-⌬F508-CFTR or the GFP-⌬F508-CFTR Y517A mutant.
X
ABCC7 p.Tyr517Ala 16131493:195:154
status: NEW197 A, summary of biotinylation experiments demonstrating that the apical membrane expression of GFP-⌬F508-CFTR and GFP-⌬F508-CFTR Y517A at steady state did not differ.
X
ABCC7 p.Tyr517Ala 16131493:197:141
status: NEW198 B, summary of biotinylation experiments demonstrating that the apical membrane half-life of GFP-⌬F508-CFTR (1.0 h) and GFP-⌬F508-CFTR Y517A (1.1 h) did not differ in CFBE41o-cells.
X
ABCC7 p.Tyr517Ala 16131493:198:148
status: NEW199 Disappearance of GFP-⌬F508-CFTR and GFP-⌬F508-CFTR Y517A from the apical membrane was monitored over time in the presence of 20 g/ml cyclohexamide (CHX) at 37 °C.
X
ABCC7 p.Tyr517Ala 16131493:199:65
status: NEW201 "C,representativeWesternblotsdemonstratingthedisappearance of GFP-⌬F508-CFTR and GFP-⌬F508-CFTR Y517A from the apical membrane over time in CFBE41o-cells.
X
ABCC7 p.Tyr517Ala 16131493:201:110
status: NEW